We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Biologicals Manufacturing Conference

Read time: Less than a minute


Biologicals Manufacturing Central London, UK 8 –9 March 2006


The 3rd Annual Biologicals Manufacturing conference draws on the experience of several biotechs from across Europe and will deliver case studies of their experiences in this field.


This conference will also cover bleeding-edge topics within this market, including the topics of glycoengineering, the use of disposables, and stability and formulation issues.



Some of the topics our experts will cover during the two-days are:


-          Manufacturing challenges in the production of cancer vaccines
-          Technology transfer
-          Stability and Formulation Issues in the Manufacture of Recombinant Albumin
-          Current trends in downstream processing
-          The use of disposables in biologicals production
-         GlycoEngineering and Glycoprofiling of cells and cell lines



 Expert speakers from the biopharmaceutical industry include:


• Dr.Tony Bradshaw, Director, bioprocess UK, BIOINDUSTRY ASSOCIATION
• Steffen Goletz, CEO, GLYCOTYPE
•  Dr. Klaus Kaiser, Manager for Downstrean Processing of Antobodies, BAYER HEALTHCARE
• Colin Love, Development Director, BIOVEX
• Dr. Steve Berenzenko, Director of Research & Development, DELTA BIOTECHNOLOGY



Please visit the website today for a full speaker list, up-to-date programme and workshop details




Contact: Rizwan Qayum on +44(0) 20 7753 4268 Quoting booking reference: TECNET

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.